Alzheimer’s disease Pathophysiology and Disease Mechanisms


Alzheimer’s disease (AD) is a progressive dementia with loss of neurons and the presence of two main microscopic neuropathological hallmarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, a rare familial form, is caused due to mutation of one out of three genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1).  Sporadic form occurs usually after age of 65 and accounts for most cases; it most likely results from a combination of genetic and influence of enviornment. Confirmed risk factors for sporadic AD are age and the presence of the E4 allele of (Apo lipoprotein E). Amyloid plaques comprise mainly of the neurotoxic peptide amyloid (Aβ, Abeta), cleaved sequentially from a larger precursor protein (APP) by two enzymes: β-secretase (also called BACE1) and γ-secretase (comprising four proteins, presenilin is one of them). If APP is first cleaved by the enzyme α-secretase rather than β-secretase then Aβ is not formed. Neurofibrillary tangles comprise mainly of the protein tau which binds with microtubules, which facilitating the neuronal transport system. Tau uncoupling from microtubules and aggregation into tangles inhibits transport and results in disassembly of microtubule. Phosphorylation of tau might have an important role in this. Selective vulnerability of neuronal systems such as the cholinergic, serotonergic, and noradrenergic and glutamatergic systems form the basis of current rational pharmacological treatment.



 


    Related Conference of Alzheimer’s disease Pathophysiology and Disease Mechanisms

    June 22-23, 2021

    32nd World Psychiatrists and Psychologists Meet

    Sydney, Australia
    June 23-24, 2021

    3rd European Autism Congress

    Paris, France
    June 28-28, 2021

    3rd World Depression Congress

    Zurich, Switzerland
    July 12-13, 2021

    Annual Virtual Congress on Applied Psychiatry

    Rome, Italy
    July 12-13, 2021

    European Online Conference on Psychiatry

    Rome, Italy
    July 19-20, 2021

    Annual World Congress on Psychiatry

    Madrid, Spain
    July 21-22, 2021

    2 nd Annual Psychiatrists and Psychologists Meet

    Toronto, Canada
    July 22-23, 2021

    2nd World Congress on Psychiatry and Psychology

    Berlin, Germany
    July 22-22, 2021

    13th International Conference on Addiction & Psychiatry

    Amsterdam, Netherlands
    September 08-09, 2021

    8th World Summit on Mental Health, Psychiatry and Wellbeing

    Barcelona, Spain
    September 23-24, 2021

    30th Euro Congress on Neurologists and Psychiatrists

    Paris, France
    October 18-19, 2021

    13th Worldwide Forum on Mental Health & Psychiatry

    Berlin, Germany
    October 29-29, 2021

    17th World Congress on Psychiatric & Mental Health Nursing

    Vancouver, Canada
    October 29-30, 2021

    Annual Neurologists and Neurosurgeons Meet

    Vancouver, Canada
    October 30-31, 2021

    2 nd Global Summit on Psychiatry and Psychotherapie

    Vancouver, Canada

    Alzheimer’s disease Pathophysiology and Disease Mechanisms Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in